Novartis | Patient Daily

Novartis

Patient Daily | May 7, 2023

Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa

Patient Daily | May 7, 2023

Novartis to present new data across oncology portfolio including Kisqali Phase III NATALEE trial in early breast cancer at ASCO

Patient Daily | May 7, 2023

Novartis Phase III APPOINT-PNH trial shows investigational oral monotherapy iptacopan improves hemoglobin to near-normal levels, leading to transfusion independence in all treatment-naïve PNH patients

Patient Daily | May 7, 2023

Novartis delivers strong sales growth, robust margin expansion and major innovation milestones. Raises FY guidance

Carol Ostrow | Feb 7, 2019

Novartis says Cosentyx better at clearing skin in psoriasis patients than Stelara

Press release submission | Dec 5, 2018

NOVARTIS: Announces longer-term analyses from pivotal Kymriah® trials that showed durable responses are maintained in patients with advanced blood cancers

Press releases submission | May 15, 2018

NOVARTIS: Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globally

Carrie Bradon | Dec 1, 2017

Novartis announces positive results of MONALEESA-7 trial

Trending

Patient Daily News Service | Jan 12, 2025

National Consumers League CEO: Federal 340b drug discount program ‘hijacked by hospitals and contract pharmacies’

Patient Daily News Service | Jan 16, 2025

FTC Chair: Report Finds 'Three Major Pharmacy Benefit Managers Hiked Costs for a Wide Range of Lifesaving Drugs, Including Medications to Treat Heart Disease and Cancer'

Patient Daily reports | Jan 14, 2025

National health reform group: 'Plenty of evidence that hospitals are not passing along' discounted drug prices under 340b program

+ Pharmaceuticals

Patient Daily | Jan 15, 2025

Dr. Peter Hotez receives 2025 Hill Prize for public health innovations